Michelle Lee outlines USPTO priorities at AIPLA Annual Meeting

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Michelle Lee outlines USPTO priorities at AIPLA Annual Meeting

Lee_Michelle_AIPLA15

USPTO Director Michelle Lee outlined her priorities during the Opening Plenary Session yesterday, in an interview with AIPLA Executive Director Lisa Jorgenson



Lee_Michelle_AIPLA15
Michelle Lee

These included timely issuance of high-quality patents, ensuring Patent Trial and Appeal Board proceedings are fair, high quality and on time, and “integrating with our core mission” the USPTO’s regional offices in Dallas, Denver, Detroit and Silicon Valley. “We’ve embarked on an unprecedented quest for [patent] quality during my time as Director of the USPTO, and we will continue to do so,” said Lee.

The USPTO is transforming its review data capture process to improve analytical capability and consistency. “We are looking at ways to really revamp the review process,” she said.

Everyone from examiners to applicants to supervisors will be working off the same criteria and will be able to see and understand these criteria, which Lee said will lead to increased transparency and uniformity. “Moreover everybody who conducts the review will have their results recorded electronically,” Lee explained. “The net result is we are going to hold a lot more data about how we are doing as an agency. Our estimate is we will have between three to five times the number of data points that we currently have.”

She said the USPTO will use “big data” analytic techniques to learn from that data, and to provide fine-tuned feedback at a technology center level and examiner level, as opposed to the agency-wide training now. “So we will be much more strategic and much more targeted,” said Lee.

Regarding PTAB changes, Lee said recent efforts include: allowing patent owners to include new testimonial evidence with their opposition to a petition for institution; having a new certification requirement that will be a more robust means with which to police misconduct; clarifying when the PTAB will switch to using a district court claim construction if a patent is about to expire; and a proposal for a pilot program that would consider changing staffing of PTAB trials to make them more efficient.

Lee also took the chance to vent her frustration with the expansion of the scope of geographical indications earlier this year under the Geneva Act of the Lisbon Agreement. “At WIPO, in spite of the fact only one sixth of WIPO members agreed to it, it passed, and that was unfortunate,” said Lee. She said the USPTO has a twofold strategy of challenging the legitimacy of the Lisbon Agreement and developing an alternative that is more consistent with US law.

“We achieved two positive outcomes,” reported Lee. The first is the Lisbon Union is now on a path to financial independence, so US companies’ PCT fees will not help fund it. “Secondly, working with other countries we were able to get the WIPO Standing Committee on Trademarks to work on an alternative to the Lisbon Agreement that is more in line with US thinking on geographical indications,” said Lee.



more from across site and SHARED ros bottom lb

More from across our site

Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
Gift this article